After Hours Summary: DECK -14.7%, ROST -10.3%, WDAY -6.7% lower on earnings; INTU +8.2%, ADSK +3.1% high on earnings; MRUS +17.8% on interim data
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: STEP +12.1%, INTU +8.2%, ADSK +3.1%
Companies trading higher in after hours in reaction to news: MRUS +17.8% (presents interim data), VSTM +12.6% (results from RAMP 205 evaluating avutometinib plus defactinib), PDSB +5.1% (provides data for VERSATILE-002), GT +2.9% (to sell the majority of its Chemical business for $650 mln), SSNC +2.7% (increases stock repurchase program 50% to $1.5 bln), CGEM +2.6% (to present data at ASCO 2025), SF +2.1% (reports April data), CADL +1.5% (to present data at ASCO 2025), COMM +1.3% (Wyre selects vCCAP Evo for network in Belgium), WY +0.7% (to acquire timberlands in NC and VA for $375 mln), IOVA +0.6% (announces results from Phase 2 C-144-01 trial), GSK +0.5% (FDA approves Nucala), LLY +0.5% (to present data at ASCO 2025), FIX +0.3% (increases stock repurchase program to 1 mln shares), BMY +0.2% (to present data at ASCO 2025), PEP +0.2% (FTC dismisses price discrimination lawsuit), AMZN +0.1% (shareholder proposal to separate CEO/Chair roles was not approved)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: DECK -14.7% (reports earnings but will not provide FY26 guidance; increases share repurchase auth to $2.5 bln; also names Chair of the Board), ROST -10.3% (report earnings, withdraws full year guidance), WDAY -6.7%, BULL -5.3%, CPRT -1.2%
Companies trading lower in after hours in reaction to news: BCAX -29.7% (interim data from Phase 1/1b Trial of Ficerafusp alfa), GYRE -15.3% (met primary endpoint in Pivotal Phase 3 Trial in China; also stock offering), XRX -9.2% (reduces dividend ahead of Lexmark transaction, reaffirms FY25 guidance), BURL -5.4% (in sympathy with weak ROST earnings), ACTU -2.5% (to present data at ASCO 2025), REGN -2% (provides data on Linvoseltamab), NTRA -1% (to present data at ASCO 2025), VECO -0.6% (files mixed securities shelf offering), EXEL -0.4% (results from Phase 1b/2 STELLAR-002 trial), MSFT -0.2% (FTC dismisses case sought to block Microsoft's acquisition of Activision Blizzard), GH -0.1% (to present data at ASCO 2025)